Comment on

• Balancing the Risk-Benefit Ratio in the Treatment of Patients With Advanced-Stage Hodgkin Lymphoma.

  Borchmann P, Engert A. Borchmann P, et al. J Clin Oncol. 2016 Jun 10;34(17):1975-7. doi: 10.1200/JCO.2015.66.3823. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069072 No abstract available.
• US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

  Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW. Press OW, et al. J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069074 Free PMC article. Clinical Trial.
• Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.

  Carde P, Karrasch M, Fortpied C, Brice P, Khaled H, Casasnovas O, Caillot D, Gaillard I, Bologna S, Ferme C, Lugtenburg PJ, Morschhauser F, Aurer I, Coiffier B, Meyer R, Seftel M, Wolf M, Glimelius B, Sureda A, Mounier N. Carde P, et al. J Clin Oncol. 2016 Jun 10;34(17):2028-36. doi: 10.1200/JCO.2015.64.5648. Epub 2016 Apr 25. J Clin Oncol. 2016. PMID: 27114593 Clinical Trial.
• Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

  Hawkes EA, Chong G, Grigg A. Hawkes EA, et al. J Clin Oncol. 2017 Jan 20;35(3):371-372. doi: 10.1200/JCO.2016.68.2047. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095269 No abstract available.
• How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?

  Hess CF, Schirmer MA. Hess CF, et al. J Clin Oncol. 2017 Jan 20;35(3):372. doi: 10.1200/JCO.2016.69.6575. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095270 No abstract available.
• Predictive Value of Interim [¹⁸F]Fluorodeoxyglucose-Positron Emission Tomography in Advanced-Stage Hodgkin Lymphoma Is Not Well Established.

  Adams HJ, Kwee TC. Adams HJ, et al. J Clin Oncol. 2017 Jan 20;35(3):370-371. doi: 10.1200/JCO.2016.68.1494. Epub 2016 Oct 28. J Clin Oncol. 2017. PMID: 28095276 No abstract available.